Biological Products, (No Diagnostic Substances)·WATERTOWN, MA
Summary Financials
Tectonic Therapeutic, Inc. — SlamSEC
Revenue
—
Adj. EBITDA
-$56.4M
FY 2025
Net Income
-$58.0M
FY 2025
EPS (Diluted)
-$6.83
FY 2025
Stock Price
$35.87
+28.7%
2026-03-06
52W Range
$13.70 – $36.03
P/E Ratio
-5.3x
Market Cap
$673.5M
Cash
$141.2M
FY 2025
Total Debt
$15.0M
FY 2022
Net Cash
$126.2M
FY 2022
Enterprise Value
$547.3M
Debt / EBITDA
2.2x
FY 2025
EV / EBITDA
-9.7x
Employees
—
Tectonics are the processes that result in the structure and properties of Earth's crust and its evolution through time. The field of planetary tectonics extends the concept to other planets and moons.